Comments
GSK offers $13/share in unsolicited Human Genome bid
19.04.2012. | LONDON (Reuters) - Human Genome Sciences Inc said on Thursday its long-time partner GlaxoSmithKline Plc had made an unsolicited proposal to buy it for $13.00 per share in cash, a move underscoring the rapid pace of deal-making in pharmaceuticals....
